The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Mitogenic Signaling via G Protein-Coupled Receptors
Abstract
RECEPTORS coupled to heterotrimeric GTP-binding proteins (G proteins) comprise the largest known family of cell surface receptors and mediate cellular responses to a diverse array of signaling molecules, including peptide and glycopeptide hormones, neurotransmitters, phospholipids, odorants, and photons. The basic unit of G protein-coupled receptor (GPCR) signaling is comprised of three parts; receptor, which detects ligand in the extracellular milieu; heterotrimeric G protein, which is dissociated into active Gα-GTP and Gβγ-subunits after interaction with the liganded receptor; and effector, which interacts with dissociated Gα-GTP and Gβγ-subunits to mediate the intracellular effects of ligand binding. In a given cell type, the responsiveness to stimulus, as well as the nature of the response, is dictated by the available complement of receptor, G protein, and effector. Despite the diverse array of ligands with which they interact, GPCRs share a conserved predicted tertiary structure characterized by seven transmembrane domains joined by intracellular and extracellular loops. G protein coupling specificity is dictated by the intracellular domains, particularly the second and third intracellular loops and the Cterminal tail. Indeed, it is possible to alter the G proteincoupling specificity of GPCRs by exchanging relatively small regions within the third intracellular loop (1).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it is well established that many GPCRs activate ERK1/2 signaling upon ligand binding (van Biesen et al., 1996)”
From GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis (2019) · cites this paper as van Biesen et al., 1996
In the citing paper
“It is well documented that many GPCRs upon ligand binding activate ERK signaling and further regulate cell growth, division and differentiation (van Biesen et al., 1996).”
From GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis (2019) · cites this paper as van Biesen et al., 1996
Citations
Cites
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Hormonal stimulation of adenylyl cyclase through Gi-protein βγ subunits
Federman, A. D., Conklin, B. R., Schrader, K. A., Reed, R. R., & Bourne, H. R. (1992) · Nature · doi:10.1038/356159a0 · Cited by 624
Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras.
Bennett, A. M., Tang, T. L., Sugimoto, S., Walsh, C. T., & Neel, B. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7335 · Cited by 397
Flagged first, then by citations
Cited by
Sorted by citations
G-protein-coupled receptors and signaling networks: emerging paradigms
Marinissen, M. J., & Gutkind, J. S. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01678-3 · Cited by 1,049
Gutkind, J. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1839 · Cited by 812
GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis
Yu, H., Rimbert, A., Palmer, A. E., Toyohara, T., Xia, Y., Xia, F., Ferreira, L. M. R., Chen, Z., Chen, T., Loaiza, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.034 · Cited by 113
Thibonnier, M., Coles, P., Conarty, D. M., Plesnicher, C. L., & Shoham, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39056-1 · Cited by 35
Metadata
- Authors
- van BIESEN, T., LUTTRELL, L. M., HAWES, B. E., & LEFKOWITZ, R. J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1996-12
- Volume
- 17
- Issue
- 6
- Pages
- 698-714
- ISSN
- 0163-769X
- 1945-7189
- Cited by
- 361
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review